These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 10344344

  • 1. Combined therapy with prednisolone, azathioprine, heparin-warfarin, and dipyridamole for paediatric patients with severe IgA nephropathy--is it relevant for adult patients?
    Yoshikawa N, Ito H.
    Nephrol Dial Transplant; 1999 May; 14(5):1097-9. PubMed ID: 10344344
    [No Abstract] [Full Text] [Related]

  • 2. Long-term results of a randomized controlled trial in childhood IgA nephropathy.
    Kamei K, Nakanishi K, Ito S, Saito M, Sako M, Ishikura K, Hataya H, Honda M, Iijima K, Yoshikawa N, Japanese Pediatric IgA Nephropathy Treatment Study Group.
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1301-7. PubMed ID: 21493743
    [Abstract] [Full Text] [Related]

  • 3. A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group.
    Yoshikawa N, Ito H, Sakai T, Takekoshi Y, Honda M, Awazu M, Ito K, Iitaka K, Koitabashi Y, Yamaoka K, Nakagawa K, Nakamura H, Matsuyama S, Seino Y, Takeda N, Hattori S, Ninomiya M.
    J Am Soc Nephrol; 1999 Jan; 10(1):101-9. PubMed ID: 9890315
    [Abstract] [Full Text] [Related]

  • 4. Disappearance of glomerular IgA deposits in childhood IgA nephropathy showing diffuse mesangial proliferation after 2 years of combination/prednisolone therapy.
    Shima Y, Nakanishi K, Kamei K, Togawa H, Nozu K, Tanaka R, Sasaki S, Iijima K, Yoshikawa N.
    Nephrol Dial Transplant; 2011 Jan; 26(1):163-9. PubMed ID: 20601366
    [Abstract] [Full Text] [Related]

  • 5. Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial.
    Yoshikawa N, Honda M, Iijima K, Awazu M, Hattori S, Nakanishi K, Ito H, Japanese Pediatric IgA Nephropathy Treatment Study Group.
    Clin J Am Soc Nephrol; 2006 May; 1(3):511-7. PubMed ID: 17699253
    [Abstract] [Full Text] [Related]

  • 6. Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT.
    Shima Y, Nakanishi K, Kaku Y, Ishikura K, Hataya H, Matsuyama T, Honda M, Sako M, Nozu K, Tanaka R, Iijima K, Yoshikawa N, Japanese Pediatric IgA Nephropathy Treatment Study Group.
    Pediatr Nephrol; 2018 Nov; 33(11):2103-2112. PubMed ID: 29987456
    [Abstract] [Full Text] [Related]

  • 7. Combination therapy with mizoribine for severe childhood IgA nephropathy: a pilot study.
    Yoshikawa N, Nakanishi K, Ishikura K, Hataya H, Iijima K, Honda M, Japanese Pediatric IgA Nephropathy Treatment Study Group.
    Pediatr Nephrol; 2008 May; 23(5):757-63. PubMed ID: 18224343
    [Abstract] [Full Text] [Related]

  • 8. Dipyridamole and low-dose warfarin without cyclophosphamide in the management of IgA nephropathy.
    Woo KT, Lee GS, Pall AA.
    Kidney Int; 2000 Jan; 57(1):348-9. PubMed ID: 10712116
    [No Abstract] [Full Text] [Related]

  • 9. [Differentiated pathogenetic therapy of glomerulonephritis].
    Belovezhdov N.
    Ter Arkh; 1987 Jan; 59(8):38-40. PubMed ID: 3686444
    [No Abstract] [Full Text] [Related]

  • 10. Combined immunosuppression and anticoagulation in rapidly progressive glomerulonephritis.
    Brown CB, Wilson D, Turner D, Cameron JS, Ogg CS, Chantler C, Gill D.
    Lancet; 1974 Nov 16; 2(7890):1166-72. PubMed ID: 4139590
    [No Abstract] [Full Text] [Related]

  • 11. [Glomerulonephritis therapy. Immunosuppression or coagulation inhibitors - a comparison].
    Schmitt E, Sinn W, Lakner V, Ratner M, Tomilina N.
    Z Gesamte Inn Med; 1980 Aug 01; 35(15):Suppl 45-8. PubMed ID: 7467565
    [Abstract] [Full Text] [Related]

  • 12. Nationwide survey on current treatments for IgA nephropathy in Japan.
    Matsuzaki K, Suzuki Y, Nakata J, Sakamoto N, Horikoshi S, Kawamura T, Matsuo S, Tomino Y.
    Clin Exp Nephrol; 2013 Dec 01; 17(6):827-33. PubMed ID: 23519367
    [Abstract] [Full Text] [Related]

  • 13. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin.
    Woo KT, Lee GS.
    Clin Nephrol; 1991 Apr 01; 35(4):184. PubMed ID: 1855324
    [No Abstract] [Full Text] [Related]

  • 14. Are anticoagulants beneficial in the treatment of rapidly progressive glomerulonephritis?
    Cameron JS.
    Proc Eur Dial Transplant Assoc; 1973 Apr 01; 10(0):57-90. PubMed ID: 4606240
    [No Abstract] [Full Text] [Related]

  • 15. Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy.
    Ballardie FW, Roberts ISD.
    J Am Soc Nephrol; 2002 Jan 01; 13(1):142-148. PubMed ID: 11752031
    [Abstract] [Full Text] [Related]

  • 16. Benefit of cyclophosphamide therapy in IgA nephritis may have been obscured by warfarin-related nephropathy in the randomized trials in which warfarin and dipyridamole were used in combination with cyclophosphamide.
    Brodsky SV, Rovin BH, Hebert LA.
    Nephrol Dial Transplant; 2012 Feb 01; 27(2):475-7. PubMed ID: 21948859
    [No Abstract] [Full Text] [Related]

  • 17. A comparison of corticosteroid and warfarin therapy in IgA nephropathy with crescent formation: preliminary trial.
    Kanno Y, Witt M, Okada H, Nemoto H, Sugahara S, Nakamoto H, Suzuki H.
    Clin Exp Nephrol; 2003 Mar 01; 7(1):48-51. PubMed ID: 14586743
    [Abstract] [Full Text] [Related]

  • 18. Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.
    Yagi K, Okada M, Yanagida H, Kuwajima H, Ikeda M, Sugimoto K, Takemura T.
    Clin Exp Nephrol; 2003 Dec 01; 7(4):270-4. PubMed ID: 14712355
    [Abstract] [Full Text] [Related]

  • 19. Effect of combined immunosuppressive anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis.
    Matousovic K, Matl I, Zabka J, Zástava V, Rossmann P, Prát V.
    Czech Med; 1985 Dec 01; 8(3):151-7. PubMed ID: 3932033
    [Abstract] [Full Text] [Related]

  • 20. Severe fibrin and crescent glomerulonephritis: clinical and morphological aspects of 33 patients.
    Mathew TH, Kincaid-Smith P.
    Perspect Nephrol Hypertens; 1973 Dec 01; 1 Pt 2(0):727-34. PubMed ID: 4803314
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.